Stockscreener 앱 받기
3.73
1.36%
0.05
전일 마감가:
$3.68
열려 있는:
$3.7
하루 거래량:
871.85K
Relative Volume:
0.55
시가총액:
$550.16M
수익:
$185.74M
순이익/손실:
$-230.76M
주가수익비율:
-4.1175
EPS:
-0.9059
순현금흐름:
$-70.72M
1주 성능:
+5.07%
1개월 성능:
+29.97%
6개월 성능:
+18.79%
1년 성능:
+83.74%
1일 변동 폭
$3.66
$3.765
1주일 범위
$3.47
$3.765
52주 변동 폭
$1.95
$4.105
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.73 | 550.16M | 185.74M | -230.76M | -70.72M | -0.9059 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Neutral |
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | 개시 | Craig Hallum | Buy |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Maravai LifeSciences (MRVI) Expected to Announce Earnings on Thursday - MarketBeat
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
What management guidance Maravai (MRVI)? (-0.14%) 2026-04-27Risk Analysis - Newser
[ARS] MARAVAI LIFESCIENCES HOLDINGS, INC. SEC Filing - Stock Titan
Maravai (MRVI) sets 2026 virtual meeting, board elections and say-on-pay - Stock Titan
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 - The National Law Review
Press Release: Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 - Moomoo
Maravai LifeSciences Holdings (MRVI) Stock Analysis: A Closer Look at a 34.90% Potential Upside - DirectorsTalk Interviews
Investors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Maravai LifeSciences (MRVI) Carrying Moderately Bullish Sentiment Despite Options-Linked Volatility - Insider Monkey
8 Best Life Sciences Penny Stocks to Buy - Insider Monkey
VIX Spike: Will Maravai LifeSciences Holdings Inc stock hit new highs in YEAR2026 Key Highlights & Smart Investment Allocation Insights - baoquankhu1.vn
How Maravai LifeSciences (MRVI) Q4 Results Are Shaping A Cautious Valuation Narrative - Yahoo Finance
Is Maravai (MRVI) Stock Stronger Than Peers | Price at $3.06, Down 0.33%Support Bounce - Newser
Chart Watch: Will Maravai LifeSciences Holdings Inc stock hit new highs in YEAR2026 Market WrapUp & AI Based Trade Execution Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Is Maravai (MRVI) Stock Priced Correctly | Price at $3.17, Up 9.86%Expert Momentum Signals - Xã Vĩnh Công
Gainers Report: How does Maravai LifeSciences Holdings Inc score in quality rankingsProfit Target & Long Hold Capital Preservation Plans - baoquankhu1.vn
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Rating of “Hold” from Brokerages - Defense World
Risk Recap: What is the dividend yield of Maravai LifeSciences Holdings IncShort Setup & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Prestige Consumer Healthcare (NYSE:PBH) and Maravai LifeSciences (NASDAQ:MRVI) Head-To-Head Survey - Defense World
Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Does Maravai LifeSciences Holdings Inc have strong fundamentals2026 Volume & Daily Momentum Trading Reports - baoquankhu1.vn
2026-03-31 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect | NDAQ:MRVI | Press Release - Stockhouse
MRVI Stockholders Have Opportunity to Lead Maravai LifeSciences H - The National Law Review
Profit Review: Can Maravai LifeSciences Holdings Inc lead its sector in growth2026 Investor Takeaways & Capital Protection Trading Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
How The Maravai LifeSciences (MRVI) Story Is Shifting As Analysts Rework Fair Value Targets - Yahoo Finance
Stop Loss: Is Maravai LifeSciences Holdings Inc in a bullish channel2026 Sector Moves & AI Based Trade Execution Alerts - baoquankhu1.vn
Recap Report: What is the dividend yield of Maravai LifeSciences Holdings IncGDP Growth & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Aug Gainers: How cyclical is CSWCs revenue stream2026 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Stop Loss: What are Maravai LifeSciences Holdings Incs earnings expectationsEarnings Performance Report & Long-Term Capital Growth Strategies - baoquankhu1.vn
Maravai LifeSciences stock faces ongoing volatility amid restructuring efforts and biotech sector pr - AD HOC NEWS
Analysts’ Top Technology Picks: Blaize Holdings (BZAI), Zeta Global Holdings Corp (ZETA) - The Globe and Mail
Published on: 2026-03-25 14:27:07 - baoquankhu1.vn
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment - BioSpace
FINAL REMINDER MRVI DEADLINE: Bronstein, Gewirtz & Grossman LLC A - The National Law Review
MRVI Shareholders Have Opportunity to Lead Maravai LifeSciences H - The National Law Review
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (M - The National Law Review
Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences Ho - The National Law Review
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Inve - The National Law Review
Maravai LifeSciences Holdings, Inc. (MRVI) reports Q4 loss, beats revenue estimates - MSN
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.45%
자본화:
|
볼륨(24시간):